较低抗苗勒管激素与肥胖女性较低获卵数相关,但与活产率无关
基于2012至2014年SART CORS数据库的回顾性队列,纳入13316例肥胖女性和16579例正常体重指数女性首次自体新鲜胚胎移植IVF周期。肥胖女性抗苗勒管激素较低且获卵数较少;在肥胖女性中,抗苗勒管激素与获卵数相关,但与活产率无关。
要点
- 肥胖女性较正常体重指数女性抗苗勒管激素更低、获卵数更少。
- 肥胖且抗苗勒管激素正常者获卵数低于正常体重指数且抗苗勒管激素正常者。
- 肥胖女性中抗苗勒管激素与获卵数相关,与活产率无关。
核心结论
- 肥胖不孕女性较低抗苗勒管激素似乎反映较低卵巢储备,因抗苗勒管激素与较低获卵数相关。
- 尽管获卵数较低,较低抗苗勒管激素与肥胖女性较低活产率无关。
研究设计与样本
- 回顾性队列研究,数据来自辅助生殖技术临床结局报告系统数据库。
- 纳入13316例肥胖女性和16579例正常体重指数女性,均为2012至2014年间首次自体体外受精新鲜移植周期。
- 正常体重指数定义为18.5-24.9 kg/m2,肥胖定义为体重指数≥30 kg/m2。
- 肥胖者按世界卫生组织指南分为1级(30.0-34.9 kg/m2)、2级(35.0-39.9 kg/m2)和3级(≥40 kg/m2)。
- 抗苗勒管激素分层为正常(>1.1 ng/mL)、低(0.16-1.1 ng/mL)和检测不到(≤0.16 ng/mL)。
主要发现
- 肥胖女性较正常体重指数女性年龄更大(36.0±4.8 vs 35.5±4.8,P<.001)。
- 肥胖女性较正常体重指数女性抗苗勒管激素更低(1.8±2.0 ng/mL vs 2.1±2.0 ng/mL,P<.001)。
- 肥胖女性较正常体重指数女性获卵数更少(11.9±7.3 vs 12.8±7.7,P<.001)。
- 肥胖且抗苗勒管激素正常者获卵数低于正常体重指数且抗苗勒管激素正常者(13.6±7.3 vs 15.8±8.1,P<.001)。
- 肥胖且抗苗勒管激素低者(P=.58)和检测不到者(P=.11)与正常体重指数且抗苗勒管激素相似者相比,获卵数无差异。
关键数值与推荐
- 抗苗勒管激素正常定义为>1.1 ng/mL。
- 抗苗勒管激素低定义为0.16-1.1 ng/mL。
- 抗苗勒管激素检测不到定义为≤0.16 ng/mL。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimüllerian hormone is produced by small antral follicles and reflects ovarian reserve. Obesity is associated with lower serum antimüllerian hormone, but it is unclear whether lower levels of antimüllerian hormone in women with obesity reflect lower ovarian reserve. OBJECTIVE: To determine whether lower antimüllerian hormone in women with obesity undergoing in vitro fertilization is associated with oocyte yield and live-birth rate. MATERIALS AND METHODS: Retrospective cohort from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database of 13,316 women with obesity and 16,579 women with normal body mass index undergoing their first autologous in vitro fertilization with fresh transfers between 2012 and 2014. Normal body mass index was defined as body mass index 18.5-24.9 kg/m2, and obesity was defined as body mass index ≥30 kg/m2. Subjects with obesity were stratified as those with class 1 obesity (body mass index, 30.0-34.9 kg/m2), class 2 obesity (body mass index, 35.0-39.9 kg/m2), and class 3 obesity (body mass index, ≥40 kg/m2) based on the World Health Organization body mass index guidelines. Antimüllerian hormone levels were stratified as normal (>1.1 ng/mL), low (0.16-1-1 ng/mL), and undetectable (≤0.16 ng/mL). Multivariable modeling was used to assess oocyte yield using linear regression with a logarithmic transformation and odds of live birth using logistic regression. RESULTS: Women with obesity were older (36.0 ± 4.8 vs 35.5 ± 4.8, P < .001), had lower antimüllerian hormone (1.8 ± 2.0 ng/mL vs 2.1 ± 2.0 ng/mL, P < .001), and had fewer oocytes retrieved (11.9 ± 7.3 vs 12.8 ± 7.7, P < .001) than women with normal body mass index. Lower oocyte yield was observed among women with obesity and normal antimüllerian hormone levels compared to women with normal body mass index and normal antimüllerian hormone levels (13.6 ± 7.3 vs 15.8 ± 8.1, P < .001). No difference in oocyte yield was observed among women with obesity and low antimüllerian hormone levels (P = .58) and undetectabl antimüllerian hormone (P = .11) compared to women with normal BMI and similar antimüllerian hormone levels. Among women with a body mass index ≥30 kg/m2, antimüllerian hormone levels were associated with the number of oocytes retrieved (β = 0.069; standard error, 0.005; P < .001) but not live-birth rate (odds ratio, 0.98; 95% confidence interval, 0.93-1.04, P = .57). CONCLUSION: Lower antimüllerian hormone in infertile women with obesity appears to reflect lower ovarian reserve, as antimüllerian hormone is associated with lower oocyte yield. Despite lower oocyte yield, lower antimüllerian hormone was not associated with lower live-birth rate among women with obesity.
引用
- Vitek W, Sun F, Baker VL, et al. Lower antimüllerian hormone is associated with lower oocyte yield but not live-birth rate among women with obesity. Am J Obstet Gynecol. 2019. PMID: 31589862. doi:10.1016/j.ajog.2019.09.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。